Punicalin Attenuates Breast Cancer-Associated Osteolysis by Inhibiting the NF-κB Signaling Pathway of Osteoclasts

Punicalin Attenuates Breast Cancer-Associated Osteolysis by Inhibiting the NF-κB Signaling Pathway of Osteoclasts

Background: Breast cancer bone metastasis and osteoporosis are both severe diseases that seriously threaten human health. These diseases are closely associated with osteolytic lesions. And osteoclasts are the key targets of this pathological process. Given the lack of effective preventive or treatme...

Full description

Bibliographic Details
Main Authors:	Tao Li, Guangyao Jiang, Xuantao Hu, Daishui Yang, Tingting Tan, Zhi Gao, Zhuoyuan Chen, Cheng Xiang, Shizhen Li, Zhengxiao Ouyang, Xiaoning Guo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Pharmacology
Subjects:	punicalin osteoclast osteoporosis osteolysis NF-κB breast cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.789552/full

Similar Items

Cimifugin Suppresses NF-κB Signaling to Prevent Osteoclastogenesis and Periprosthetic Osteolysis
by: Juan Duan, et al.
Published: (2021-09-01)

Chrysin Protects Against Titanium Particle-Induced Osteolysis by Attenuating Osteoclast Formation and Function by Inhibiting NF-κB and MAPK Signaling
by: Zuoxing Wu, et al.
Published: (2022-03-01)

Punicalin attenuates LPS-induced acute lung injury by inhibiting inflammatory cytokine production and MAPK/NF-κB signaling in mice
by: Wentao Ji, et al.
Published: (2023-04-01)

Tussilagone Inhibits Osteoclastogenesis and Periprosthetic Osteolysis by Suppressing the NF-κB and P38 MAPK Signaling Pathways
by: Xuantao Hu, et al.
Published: (2020-04-01)

Punicalin Ameliorates Cell Pyroptosis Induced by LPS/ATP Through Suppression of ROS/NLRP3 Pathway
by: Shen R, et al.
Published: (2021-03-01)

Aconine attenuates osteoclast-mediated bone resorption and ferroptosis to improve osteoporosis via inhibiting NF-κB signaling
by: Chunchun Xue, et al.
Published: (2023-11-01)

Rubidium Chloride Targets Jnk/p38-Mediated NF-κB Activation to Attenuate Osteoclastogenesis and Facilitate Osteoblastogenesis
by: Zhengxiao Ouyang, et al.
Published: (2019-05-01)

Desferrioxamine alleviates UHMWPE particle-induced osteoclastic osteolysis by inhibiting caspase-1-dependent pyroptosis in osteocytes
by: Shenli Zhao, et al.
Published: (2022-12-01)

Total flavonoids from celery suppresses RANKL-induced osteoclast differentiation and bone resorption function via attenuating NF-κB and p38 pathways in RAW264.7 cells
by: Lujuan Jia, et al.
Published: (2020-06-01)

In vitro and in vivo antioxidant activities of three major polyphenolic compounds in pomegranate peel: Ellagic acid, punicalin, and punicalagin
by: Yu-qing SUN, et al.
Published: (2017-08-01)

Mechanism of regulating macrophages/osteoclasts in attenuating wear particle-induced aseptic osteolysis
by: Zhaoyang Yin, et al.
Published: (2023-10-01)

Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways
by: Li X, et al.
Published: (2021-01-01)

Dihydromyricetin Protects against Bone Loss in Ovariectomized Mice by Suppressing Osteoclast Activity
by: Libo Zhao, et al.
Published: (2017-12-01)

Amyloid β Peptide Enhances RANKL-Induced Osteoclast Activation through NF-κB, ERK, and Calcium Oscillation Signaling
by: Shangfu Li, et al.
Published: (2016-10-01)

Phillyrin Attenuates Osteoclast Formation and Function and Prevents LPS-Induced Osteolysis in Mice
by: Jing Wang, et al.
Published: (2019-10-01)

Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways
by: Xue Yang, et al.
Published: (2021-06-01)

Peiminine Suppresses RANKL-Induced Osteoclastogenesis by Inhibiting the NFATc1, ERK, and NF-κB Signaling Pathways
by: Mengbo Zhu, et al.
Published: (2021-09-01)

Isoliensinine Suppresses Osteoclast Formation Through NF-κB Signaling Pathways and Relieves Ovariectomy-Induced Bone Loss
by: Huijiang Liu, et al.
Published: (2022-07-01)

(<i>S</i>)-2-(Cyclobutylamino)-<i>N</i>-(3-(3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)-2-hydroxypropyl)isonicotinamide Attenuates RANKL-Induced Osteoclast Differentiation by Inhibiting NF-κB Nuclear Translocation
by: Mina Ding, et al.
Published: (2023-02-01)

Effect of Bifidobacterium on osteoclasts: TNF-α/NF-κB inflammatory signal pathway-mediated mechanism
by: Yue Wu, et al.
Published: (2023-03-01)

Inhibition of Osteoclast Differentiation by Carotenoid Derivatives through Inhibition of the NF-κB Pathway
by: Shlomit Odes-Barth, et al.
Published: (2020-11-01)

SPHK Inhibitors and Zoledronic Acid Suppress Osteoclastogenesis and Wear Particle-Induced Osteolysis
by: Minghui Gu, et al.
Published: (2022-02-01)

Piperlongumine Inhibits Titanium Particles-Induced Osteolysis, Osteoclast Formation, and RANKL-Induced Signaling Pathways
by: Xuan Liu, et al.
Published: (2022-03-01)

Trimethylamine-N-Oxide Promotes Osteoclast Differentiation and Bone Loss via Activating ROS-Dependent NF-κB Signaling Pathway
by: Ning Wang, et al.
Published: (2022-09-01)

Garcinone C attenuates RANKL-induced osteoclast differentiation and oxidative stress by activating Nrf2/HO-1 and inhibiting the NF-kB signaling pathway
by: Hongyun Ji, et al.
Published: (2024-02-01)

Zebrafish <i>mafbb</i> Mutants Display Osteoclast Over-Activation and Bone Deformity Resembling Osteolysis in MCTO Patients
by: Yujie Han, et al.
Published: (2021-03-01)

Oroxin B Attenuates Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Formation and Activity
by: Huang JM, et al.
Published: (2021-11-01)

Key Triggers of Osteoclast-Related Diseases and Available Strategies for Targeted Therapies: A Review
by: Haidi Bi, et al.
Published: (2017-12-01)

Oligosaccharides from Sargassum thunbergii inhibit osteoclast differentiation via regulation of IRF-8 signaling
by: Weihua Jin, et al.
Published: (2023-02-01)

HTRA1 from OVX rat osteoclasts causes detrimental effects on endplate chondrocytes through NF-κB
by: Longting Chen, et al.
Published: (2023-06-01)

Echinacoside Inhibits Osteoclast Function by Down-Regulating PI3K/Akt/C-Fos to Alleviate Osteolysis Caused by Periprosthetic Joint Infection
by: Tao Jiang, et al.
Published: (2022-06-01)

The ketone body β-hydroxybutyrate alleviates CoCrMo alloy particles induced osteolysis by regulating NLRP3 inflammasome and osteoclast differentiation
by: Yanglin Wu, et al.
Published: (2022-03-01)

Mitigation of inflammatory bowel disease-related osteoporosis by oxyberberine: Insights into the RANKL/NF-κB signaling pathway
by: Tingting Chen, et al.
Published: (2024-05-01)

Recombinant Human Endostatin Suppresses Mouse Osteoclast Formation by Inhibiting the NF-κB and MAPKs Signaling Pathways
by: Non eChen, et al.
Published: (2016-06-01)

Pexmetinib suppresses osteoclast formation and breast cancer induced osteolysis via P38/STAT3 signal pathway
by: Zhiwei Jie, et al.
Published: (2022-08-01)

Extracorporeal shock wave therapy inhibits osteoclast differentiation by targeting NF-κB signaling pathway
by: Bei Chen, et al.
Published: (2023-10-01)

Inflammatory osteolysis is regulated by site-specific ISGylation of the scaffold protein NEMO
by: Naga Suresh Adapala, et al.
Published: (2020-03-01)

Effects of Taxifolin on Osteoclastogenesis in vitro and in vivo
by: Cong Cai, et al.
Published: (2018-11-01)

Celastrol Attenuates RANKL-Induced Osteoclastogenesis in vitro and Reduces Titanium Particle-Induced Osteolysis and Ovariectomy-Induced Bone Loss in vivo
by: Qiang Xu, et al.
Published: (2021-06-01)

Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation
by: Zhe-Kun Jia, et al.
Published: (2018-02-01)